rs6082

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000236.3(LIPC):​c.591A>G​(p.Gly197Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.098 in 1,613,402 control chromosomes in the GnomAD database, including 11,312 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1148 hom., cov: 34)
Exomes 𝑓: 0.097 ( 10164 hom. )

Consequence

LIPC
NM_000236.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.09

Publications

22 publications found
Variant links:
Genes affected
LIPC (HGNC:6619): (lipase C, hepatic type) Enables phospholipase A1 activity and triglyceride lipase activity. Involved in several processes, including lipid homeostasis; plasma lipoprotein particle remodeling; and triglyceride catabolic process. Located in extracellular space. Implicated in several diseases, including Alzheimer's disease; coronary artery disease; familial combined hyperlipidemia; peripheral vascular disease; and type 2 diabetes mellitus. Biomarker of hyperinsulinism; obesity; and type 1 diabetes mellitus. [provided by Alliance of Genome Resources, Apr 2022]
LIPC Gene-Disease associations (from GenCC):
  • hyperlipidemia due to hepatic triglyceride lipase deficiency
    Inheritance: AR, Unknown Classification: STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-58545758-A-G is Benign according to our data. Variant chr15-58545758-A-G is described in ClinVar as Benign. ClinVar VariationId is 316664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIPCNM_000236.3 linkc.591A>G p.Gly197Gly synonymous_variant Exon 5 of 9 ENST00000299022.10 NP_000227.2 P11150A6H8L5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIPCENST00000299022.10 linkc.591A>G p.Gly197Gly synonymous_variant Exon 5 of 9 1 NM_000236.3 ENSP00000299022.5 P11150

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15825
AN:
151996
Hom.:
1148
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0914
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.0804
Gnomad EAS
AF:
0.415
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0781
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.128
AC:
32071
AN:
251258
AF XY:
0.121
show subpopulations
Gnomad AFR exome
AF:
0.0918
Gnomad AMR exome
AF:
0.207
Gnomad ASJ exome
AF:
0.0790
Gnomad EAS exome
AF:
0.418
Gnomad FIN exome
AF:
0.106
Gnomad NFE exome
AF:
0.0781
Gnomad OTH exome
AF:
0.0971
GnomAD4 exome
AF:
0.0974
AC:
142273
AN:
1461288
Hom.:
10164
Cov.:
40
AF XY:
0.0966
AC XY:
70260
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.0883
AC:
2957
AN:
33472
American (AMR)
AF:
0.201
AC:
8987
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0818
AC:
2138
AN:
26132
East Asian (EAS)
AF:
0.441
AC:
17495
AN:
39694
South Asian (SAS)
AF:
0.105
AC:
9048
AN:
86250
European-Finnish (FIN)
AF:
0.109
AC:
5833
AN:
53398
Middle Eastern (MID)
AF:
0.0650
AC:
374
AN:
5758
European-Non Finnish (NFE)
AF:
0.0800
AC:
88922
AN:
1111484
Other (OTH)
AF:
0.108
AC:
6519
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
6304
12609
18913
25218
31522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3628
7256
10884
14512
18140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15840
AN:
152114
Hom.:
1148
Cov.:
34
AF XY:
0.108
AC XY:
8030
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0913
AC:
3791
AN:
41510
American (AMR)
AF:
0.151
AC:
2315
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0804
AC:
279
AN:
3470
East Asian (EAS)
AF:
0.416
AC:
2145
AN:
5158
South Asian (SAS)
AF:
0.121
AC:
582
AN:
4804
European-Finnish (FIN)
AF:
0.109
AC:
1155
AN:
10576
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0781
AC:
5308
AN:
67998
Other (OTH)
AF:
0.107
AC:
225
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
725
1450
2175
2900
3625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0849
Hom.:
1451
Bravo
AF:
0.112
Asia WGS
AF:
0.271
AC:
941
AN:
3478
EpiCase
AF:
0.0766
EpiControl
AF:
0.0719

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperlipidemia due to hepatic triglyceride lipase deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.4
DANN
Benign
0.43
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6082; hg19: chr15-58837957; COSMIC: COSV54422892; API